Xtx Topco LTD Summit Therapeutics Inc. Transaction History
Xtx Topco LTD
- $2.23 Billion
- Q2 2025
A detailed history of Xtx Topco LTD transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 43,448 shares of SMMT stock, worth $987,138. This represents 0.04% of its overall portfolio holdings.
Number of Shares
43,448Holding current value
$987,138% of portfolio
0.04%Shares
4 transactions
Others Institutions Holding SMMT
# of Institutions
261Shares Held
90.4MCall Options Held
4.71MPut Options Held
3.17M-
Baker Bros. Advisors LP New York, NY33.7MShares$766 Million7.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$197 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$179 Million0.0% of portfolio
-
State Street Corp Boston, MA4.02MShares$91.3 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.91MShares$88.7 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.57B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...